prospective evaluation of prostate cancer stage at diagnosis in poland
... prostatectomy, in almost half of the cases the local stage of the tumor was underestimated [18]. Sub-analysis of presented data according to 4 different centers showed that the rates of locally advanced PCa differed substantially and amounted to 6.1%, 12%, 25.3% and 37.8%. The mean PSA and mean age ...
... prostatectomy, in almost half of the cases the local stage of the tumor was underestimated [18]. Sub-analysis of presented data according to 4 different centers showed that the rates of locally advanced PCa differed substantially and amounted to 6.1%, 12%, 25.3% and 37.8%. The mean PSA and mean age ...
looking at the prostates of patients with bladder cancer
... Authors attempted to incorporate PSA levels into predictive models of tumour significance. However, Winkler et al. [9] found a weak correlation between PSA levels and tumour volume, and no difference between median PSA values for patients with and without prostate cancer. Revelo et al. [7] reported ...
... Authors attempted to incorporate PSA levels into predictive models of tumour significance. However, Winkler et al. [9] found a weak correlation between PSA levels and tumour volume, and no difference between median PSA values for patients with and without prostate cancer. Revelo et al. [7] reported ...
Advanced prostate cancer: managing cancer that has
... bones. This is called bone metastasis. For men with advanced prostate cancer, it is important to keep bones healthy and strong. Diet, exercise, and medical therapies can help men maintain their daily activities and prevent problems such as bone fracture (breaks). ...
... bones. This is called bone metastasis. For men with advanced prostate cancer, it is important to keep bones healthy and strong. Diet, exercise, and medical therapies can help men maintain their daily activities and prevent problems such as bone fracture (breaks). ...
Management of castration resistant prostate cancer after first line
... prostate cancer after first line hormonal therapy fails ...
... prostate cancer after first line hormonal therapy fails ...
Prostate Cancer Awareness Month, Philippines
... This discussion should take place starting at age 45 for men at high risk of developing prostate cancer. This includes those who have a first-degree relative (father, brother, or son) diagnosed with prostate cancer at an early age (younger than age 65). ...
... This discussion should take place starting at age 45 for men at high risk of developing prostate cancer. This includes those who have a first-degree relative (father, brother, or son) diagnosed with prostate cancer at an early age (younger than age 65). ...
Protecting Your Prostate
... The prostate gland is a walnut-sized gland found in men that is located below the bladder and in front of the rectum. It surrounds the urethra, the tube through which urine and semen exit the body. Its main function is to produce seminal fluid so sperm can be transported through the urethra. The pro ...
... The prostate gland is a walnut-sized gland found in men that is located below the bladder and in front of the rectum. It surrounds the urethra, the tube through which urine and semen exit the body. Its main function is to produce seminal fluid so sperm can be transported through the urethra. The pro ...
Emerging Therapies for Prostate Cancer
... 1.8% (4/221) of patients did not have the intended therapeutic benefit of abarelix, as correlated with testosterone values >50 ng/dL. ...
... 1.8% (4/221) of patients did not have the intended therapeutic benefit of abarelix, as correlated with testosterone values >50 ng/dL. ...
Chemotherapy in prostate cancer
... locally advanced prostate cancer in at least two studies In the only trial with long-enough follow-up to estimate the impact on disease control, neoadjuvant ADT plus chemotherapy (two 21-day cycles of estramustine plus oral etoposide, followed by oral estramustine concurrent with 3D-CRT) was admini ...
... locally advanced prostate cancer in at least two studies In the only trial with long-enough follow-up to estimate the impact on disease control, neoadjuvant ADT plus chemotherapy (two 21-day cycles of estramustine plus oral etoposide, followed by oral estramustine concurrent with 3D-CRT) was admini ...
Prostate Cancer Treatment Options - California Pacific Medical Center
... Prostate Cancer Prostate cancer is the most common cancer in American men today, and the second-leading cause of cancer-related death. The most appropriate treatment choice for prostate cancer depends on many factors, including tumor volume and stage or extent of cancer, the pathologic Gleason scor ...
... Prostate Cancer Prostate cancer is the most common cancer in American men today, and the second-leading cause of cancer-related death. The most appropriate treatment choice for prostate cancer depends on many factors, including tumor volume and stage or extent of cancer, the pathologic Gleason scor ...
Randomized Trial Examining the Effect of Two Prostate Cancer
... behavior through their influence on cognitive and environmental processes. The study interventions are designed primarily to enhance patient knowledge. Hence, education, personal history of prostate or urologic problems, family history of CaP, prior PSA testing, and morbid conditions are included as ...
... behavior through their influence on cognitive and environmental processes. The study interventions are designed primarily to enhance patient knowledge. Hence, education, personal history of prostate or urologic problems, family history of CaP, prior PSA testing, and morbid conditions are included as ...
Therapeutic options for a rising PSA after radical prostatectomy
... pelvis. The probability that a bone scan will be positive is less than 5% until the PSA reaches 40 ng/mL-45 ng/ mL.24 If men demonstrate confined local recurrence, possibilities for salvage local therapies (surgery, cryotherapy, or radiotherapy) can be considered.25 In this setting, several studies ...
... pelvis. The probability that a bone scan will be positive is less than 5% until the PSA reaches 40 ng/mL-45 ng/ mL.24 If men demonstrate confined local recurrence, possibilities for salvage local therapies (surgery, cryotherapy, or radiotherapy) can be considered.25 In this setting, several studies ...
Secondary Hormone Therapy for Castration
... develop castration-resistant prostate cancer (CRPC). CRPC is defined by prostate-specific antigen (PSA) or radiographic progression in the context of castrate levels of testosterone.[1] CRPC patients may or may not have obvious metastases. Like all stages of prostate cancer, the natural history of n ...
... develop castration-resistant prostate cancer (CRPC). CRPC is defined by prostate-specific antigen (PSA) or radiographic progression in the context of castrate levels of testosterone.[1] CRPC patients may or may not have obvious metastases. Like all stages of prostate cancer, the natural history of n ...
Prostate Cancer Awareness Month in New Jersey
... Any of these symptoms may be caused by cancer or by other, less serious health problems, such as benign prostatic hyperplasia (BPH) or an infection. A man who has symptoms like these should see his doctor or a urologist (a doctor who specializes in treating diseases of the genitourinary system). ...
... Any of these symptoms may be caused by cancer or by other, less serious health problems, such as benign prostatic hyperplasia (BPH) or an infection. A man who has symptoms like these should see his doctor or a urologist (a doctor who specializes in treating diseases of the genitourinary system). ...
Longterm survival after radical prostatectomy versus externalbeam
... Numerous published studies have addressed the efficacy of radical prostatectomy for the treatment of high-risk prostate cancer. One such study was the retrospective review published by Bastian et al.2 This group evaluated a cohort of high-risk patients, defined as Gleason sum 8-10 and treated with r ...
... Numerous published studies have addressed the efficacy of radical prostatectomy for the treatment of high-risk prostate cancer. One such study was the retrospective review published by Bastian et al.2 This group evaluated a cohort of high-risk patients, defined as Gleason sum 8-10 and treated with r ...
Prostate Cancer Active Surveillance Guidance
... 5. The rationale for active surveillance PSA based prostate cancer screening results in the diagnosis of prostate cancer in many men who will have no progression of the disease during their lifetime.3,4,5,6 The use of curative treatments (radical prostatectomy, radiation therapy) therefore carries ...
... 5. The rationale for active surveillance PSA based prostate cancer screening results in the diagnosis of prostate cancer in many men who will have no progression of the disease during their lifetime.3,4,5,6 The use of curative treatments (radical prostatectomy, radiation therapy) therefore carries ...
